CLINUVEL Reports Tenth Consecutive Half Year Net Profit
KEY HIGHLIGHTS, HALF YEAR ENDED 31 DECEMBER 2020 Consolidated Entity Result Change...
Read More
Appendix 4D Half Year Report
Results For Announcement To The Market ($A’000) Revenues from continuing activities Increased...
Read More
Financial Results Half Year Ended 31 December 2020
Operations Update I Webinar CLINUVEL PHARMACEUTICALS LTD CLINUVEL PHARMACEUTICALS LTD will host...
Read More
Appendix 4C & Activity Report
Melbourne, Australia, 28 January 2021 CLINUVEL PHARMACEUTICALS LTD today announced its Appendix...
Read More
Change in substantial holding
22 December 2020 Form 604 Corporations Act 2001 Section 671B Notice of...
Read More
APPENDIX 4C AND ACTIVITY REPORT
KEY HIGHLIGHTS: SEPTEMBER QUARTER 2020 • Cash receipts of $12,015,000 • Operating...
Read More
Appendix 4G and Corporate Governance Statement
Download Appendix 4G and Corporate Governance Statement
Read More
CLINUVEL Full Year Results 2020
CLINUVEL REPORTS PROFIT, RENVESTING IN BUSINESS Fourth consecutive annual positive net cash...
Read More
CLINUVEL Webinar – Preliminary Financial Results
https://www.youtube.com/watch?v=rLSYrRRR83Y&feature=emb_title
Read More
Appendix 4C – quarterly
CLINUVEL PHARMACEUTICALS LTD today announced its Appendix 4C – Quarterly Cashflow Report...
Read More
Appendix 4C
CLINUVEL PHARMACEUTICALS LTD, a global biopharmaceutical company focused on developing and delivering...
Read More